Acasti Pharma Inc (NASDAQ:ACST)
| 0.435 Delayed Data As of Mar 24 |  0.00 / 0.00%Today’s Change | 0.34 Today|||52-Week Range 1.35 | -13.17% Year-to-Date |
Latest ACST News | Press Releases
No recent news for Acasti Pharma Inc.
Today’s Trading
| Previous close | 0.44 |
| Today’s open | 0.42 |
| Day’s range | 0.42 - 0.44 |
| Volume | 200 |
| Average volume (3 months) | 184,585 |
| Market cap | $20.0M |
Data as of 3:38pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -60.64% |
| Earnings growth (this year) | -56.79% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYCNCyclerion Therapeuti... | -0.02 | -5.11% |
| SLNOSoleno Therapeutics ... | +0.18 | +8.29% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | June 28, 2023 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
